Announcements Trials
Browse Landscape

Status

Unknown 5Completed 5Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 35Observational 5

Sponsor

Cancer Type

Genitourinary 4Breast 1

Conditions

Prostatic Neoplasms 3Sarcopenia 1Breast Neoplasms 1Advanced Prostate Cancer 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 59Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Bevacizumab 40Reverse Transcriptase Polymerase Chain Reaction 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Hepatectomy 25Therapeutics 24Neoadjuvant Therapy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Observational × Gonadotropin-Releasing Hormone × Clear all
NCT07127315 2025-08-17

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Helwan University

Completed
100 enrolled
Breast

Breast Neoplasms

NCT03867357 2024-09-04

Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

Seattle Institute for Biomedical and Clinical Research

Completed
60 enrolled
Genitourinary

Prostatic Neoplasms, Sarcopenia

NCT02630641 2023-05-12

EQUINOXE

Ipsen

Completed
1,000 enrolled
Genitourinary

Prostatic Neoplasms

NCT02234089 2019-07-05

ProComD

Ferring Pharmaceuticals

Completed
461 enrolled
Genitourinary

Advanced Prostate Cancer

NCT01729676 2014-07-17

FACT

Ferring Pharmaceuticals

Completed
315 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡